Similar articles

• Reply to Oluf Anderson's reply: Predicting a window of therapeutic opportunity in multiple sclerosis.

  Ebers G, Daumer M, Scalfari A. Ebers G, et al. Brain. 2011 May;134(Pt 5):e175; author reply e176. doi: 10.1093/brain/awq338. Epub 2011 Feb 8. Brain. 2011. PMID: 21303856 No abstract available.
• Prognosis of multiple sclerosis: clinical factors predicting the late evolution for an early treatment decision.

  Bergamaschi R. Bergamaschi R. Expert Rev Neurother. 2006 Mar;6(3):357-64. doi: 10.1586/14737175.6.3.357. Expert Rev Neurother. 2006. PMID: 16533140 Review.
• [Multiple sclerosis--symptoms, diagnosis and treatment].

  Elíasdóttir OJ, Olafsson E, Kjartansson O. Elíasdóttir OJ, et al. Laeknabladid. 2009 Sep;95(9):583-9. Laeknabladid. 2009. PMID: 19738293 Review. Icelandic.
• Predicting a window of therapeutic opportunity in multiple sclerosis.

  Ebers G, Daumer M, Scalfari A. Ebers G, et al. Brain. 2010 Dec;133(Pt 12):e162; author reply e163. doi: 10.1093/brain/awq226. Epub 2010 Aug 30. Brain. 2010. PMID: 20805100 No abstract available.
• Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis.

  Frohman EM, Havrdova E, Lublin F, Barkhof F, Achiron A, Sharief MK, Stuve O, Racke MK, Steinman L, Weiner H, Olek M, Zivadinov R, Corboy J, Raine C, Cutter G, Richert J, Filippi M. Frohman EM, et al. Arch Neurol. 2006 Apr;63(4):614-9. doi: 10.1001/archneur.63.4.614. Arch Neurol. 2006. PMID: 16606781 No abstract available.